ATE163422T1 - Anti-proliferative -und anti-inflammatorische verbindungen: 5- oder6-deoxyhexose monosaccharide die, in 5- oder 6-stellung einen, über das stickstoffatom gebundenen gesättigten stickstoffhaltigen heterozyklen, haben - Google Patents
Anti-proliferative -und anti-inflammatorische verbindungen: 5- oder6-deoxyhexose monosaccharide die, in 5- oder 6-stellung einen, über das stickstoffatom gebundenen gesättigten stickstoffhaltigen heterozyklen, habenInfo
- Publication number
- ATE163422T1 ATE163422T1 AT93900164T AT93900164T ATE163422T1 AT E163422 T1 ATE163422 T1 AT E163422T1 AT 93900164 T AT93900164 T AT 93900164T AT 93900164 T AT93900164 T AT 93900164T AT E163422 T1 ATE163422 T1 AT E163422T1
- Authority
- AT
- Austria
- Prior art keywords
- containing heterocycle
- proliferative
- monosaccharides
- compounds
- deoxyhexose
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 230000003110 anti-inflammatory effect Effects 0.000 title abstract 2
- 230000001028 anti-proliverative effect Effects 0.000 title abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 title abstract 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen(.) Chemical class [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 title 2
- -1 6-deoxy hexose monosaccharides Chemical class 0.000 abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/24—Heterocyclic radicals containing oxygen or sulfur as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81090691A | 1991-12-20 | 1991-12-20 | |
| US07/905,320 US5360792A (en) | 1991-12-20 | 1992-06-29 | Anti-proliferative and anti-inflammatory compounds: 5- or 6-deoxy hexose monosaccharides having a saturated nitrogen-containing heterocycle at the 5- or 6-position bound through the nitrogen atom |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE163422T1 true ATE163422T1 (de) | 1998-03-15 |
Family
ID=27123396
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93900164T ATE163422T1 (de) | 1991-12-20 | 1992-12-18 | Anti-proliferative -und anti-inflammatorische verbindungen: 5- oder6-deoxyhexose monosaccharide die, in 5- oder 6-stellung einen, über das stickstoffatom gebundenen gesättigten stickstoffhaltigen heterozyklen, haben |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5360792A (enExample) |
| EP (1) | EP0581916B1 (enExample) |
| JP (1) | JPH06508152A (enExample) |
| CN (1) | CN1077198A (enExample) |
| AT (1) | ATE163422T1 (enExample) |
| CA (1) | CA2104477A1 (enExample) |
| DE (1) | DE69224520T2 (enExample) |
| FI (1) | FI106863B (enExample) |
| IL (1) | IL104112A (enExample) |
| NZ (1) | NZ246305A (enExample) |
| TW (1) | TW293013B (enExample) |
| WO (1) | WO1993013117A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5432163A (en) * | 1992-11-13 | 1995-07-11 | Greenwich Pharmaceuticals Incorporated | Anti-proliferative and anti-inflammatory compounds: derivatives of pentose monosaccharides |
| DE69432593T2 (de) * | 1993-06-11 | 2003-11-27 | Boston Life Sciences, Inc. | Immunomodulierende, entzündungshemmende und antiproliferative verbindungen:5,6-dideoxy, 5-aminoderivate von idose und 6-deoxy, 6-aminoderivate von glukose |
| US6329344B1 (en) | 1998-10-22 | 2001-12-11 | Ranbaxy Laboratories Limited | Derivatives of monosaccharides as cell adhesion inhibitors |
| CN1338947B (zh) | 1999-02-05 | 2012-11-14 | 爱尔开-阿贝优公司 | 粘膜递送系统 |
| WO2005092907A2 (en) * | 2004-03-26 | 2005-10-06 | Ranbaxy Laboratories Limited | Monosaccharide derivatives as anti-cancer and anti-inflammatory agents |
| WO2005100373A2 (en) * | 2004-04-13 | 2005-10-27 | Ranbaxy Laboratories Limited | Monosaccharide derivatives as anti-cancer and anti-inflammatory agents |
| EP2583678A3 (en) * | 2004-06-24 | 2013-11-13 | Novartis Vaccines and Diagnostics, Inc. | Small molecule immunopotentiators and assays for their detection |
| EP1789428A1 (en) * | 2004-09-02 | 2007-05-30 | Ranbaxy Laboratories Limited | Monosaccharide derivatives |
| JP2008525421A (ja) * | 2004-12-22 | 2008-07-17 | ランバクシー ラボラトリーズ リミテッド | モノサッカリド誘導体 |
| US20080114031A1 (en) * | 2006-03-29 | 2008-05-15 | Sattigeri Viswajanani J | Monosaccharide derivatives |
| US7790689B2 (en) * | 2006-05-30 | 2010-09-07 | Ranbaxy Laboratories Limited | Monosaccharide derivatives |
| US20080300196A1 (en) * | 2006-10-03 | 2008-12-04 | Ashwani Kumar Verma | Monosaccharide derivatives |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2715121A (en) * | 1950-09-09 | 1955-08-09 | American Home Prod | Alkyl sugar derivatives and their preparation |
| US3939146A (en) * | 1973-03-01 | 1976-02-17 | Strategic Medical Research Corporation | Novel ethereal monosubstitutions of monosaccharide derivatives |
| US3965262A (en) * | 1973-03-01 | 1976-06-22 | Strategic Medical Research Corporation | Method of enhancing learning and/or memory in warm blooded animals |
| USRE30379E (en) * | 1973-03-01 | 1980-08-19 | Strategic Medical Research Corp. | Ethereal monosubstitutions of monosaccharide derivatives |
| USRE32268E (en) * | 1973-03-01 | 1986-10-21 | Strategic Medical Research Corp. | Therapeutic composition and method of therapeutically treating warm blooded animals therewith |
| US4016261A (en) * | 1973-03-01 | 1977-04-05 | Strategic Medical Research Corporation | Therapeutic composition and method of therapeutically treating warm blooded animals therewith |
| US3939145A (en) * | 1973-03-01 | 1976-02-17 | Strategic Medical Research Corporation | Novel ethereally monosubstituted monosaccharides |
| US4017608A (en) * | 1973-12-14 | 1977-04-12 | Strategic Medical Research Corporation | Therapeutic composition and method of therapeutically treating warm blooded animals therewith |
| US4056322A (en) * | 1973-12-14 | 1977-11-01 | Strategic Medical Research Corporation | Preparation of ethers of monosaccharides |
| GB1589916A (en) * | 1976-11-16 | 1981-05-20 | Prodotti Antibiotici Spa | Glucofuranose derivatives |
| USRE30354E (en) * | 1978-02-17 | 1980-07-29 | Strategic Medical Research Corp. | Novel ethereally monosubstituted monosaccharides |
| USRE33000E (en) * | 1981-01-12 | 1989-07-25 | Greenwich Pharmaceuticals, Incorporated | Therapeutic composition and method of treating viruses |
| US4738953A (en) * | 1981-02-17 | 1988-04-19 | Greenwich Pharmaceuticals Incorporated | Method of therapeutically treating a warm blooded animal afflicted with an autoimmune disease and a synergistic composition therefor |
| US4735934A (en) * | 1981-02-17 | 1988-04-05 | Greenwich Pharmaceuticals Incorporated | Method of therapeutically treating a warm blooded animal afflicted with an autoimmune disease |
| US4996195A (en) * | 1989-01-09 | 1991-02-26 | Greenwich Pharmaceuticals Inc. | Derivatives of α,D-glucofuranose or α,D-allofuranose and intermediates for preparing these derivatives |
| US5010058A (en) * | 1989-06-22 | 1991-04-23 | 501 Greenwich Pharmaceuticals Incorporated | 3,5,6-substituted derivatives of 1,2-O-isopropylidene-α,D-glucofuranose and intermediates for preparing these derivatives |
| CA2091587A1 (en) * | 1990-09-12 | 1992-03-13 | Sudershan K. Arora | Monosaccharides having anti-proliferation and anti-inflammatory activity, compositions and uses thereof |
| IL100833A0 (en) * | 1991-02-20 | 1992-09-06 | Greenwich Pharma | Method for synthesis of ethereally substituted blocked monosaccharides |
-
1992
- 1992-06-29 US US07/905,320 patent/US5360792A/en not_active Expired - Fee Related
- 1992-12-16 IL IL104112A patent/IL104112A/xx not_active IP Right Cessation
- 1992-12-18 DE DE69224520T patent/DE69224520T2/de not_active Expired - Fee Related
- 1992-12-18 JP JP5511713A patent/JPH06508152A/ja active Pending
- 1992-12-18 EP EP93900164A patent/EP0581916B1/en not_active Expired - Lifetime
- 1992-12-18 WO PCT/US1992/010775 patent/WO1993013117A2/en not_active Ceased
- 1992-12-18 CA CA002104477A patent/CA2104477A1/en not_active Abandoned
- 1992-12-18 NZ NZ246305A patent/NZ246305A/en unknown
- 1992-12-18 AT AT93900164T patent/ATE163422T1/de not_active IP Right Cessation
- 1992-12-21 CN CN92115360A patent/CN1077198A/zh active Pending
-
1993
- 1993-01-29 TW TW082100540A patent/TW293013B/zh active
- 1993-08-19 FI FI933654A patent/FI106863B/fi active
Also Published As
| Publication number | Publication date |
|---|---|
| AU3249593A (en) | 1993-07-28 |
| TW293013B (enExample) | 1996-12-11 |
| EP0581916B1 (en) | 1998-02-25 |
| DE69224520D1 (de) | 1998-04-02 |
| EP0581916A1 (en) | 1994-02-09 |
| CN1077198A (zh) | 1993-10-13 |
| US5360792A (en) | 1994-11-01 |
| WO1993013117A3 (en) | 1993-09-30 |
| AU665977B2 (en) | 1996-01-25 |
| FI933654A0 (fi) | 1993-08-19 |
| FI933654L (fi) | 1993-08-19 |
| DE69224520T2 (de) | 1998-07-23 |
| FI106863B (fi) | 2001-04-30 |
| CA2104477A1 (en) | 1993-06-21 |
| IL104112A (en) | 1997-09-30 |
| JPH06508152A (ja) | 1994-09-14 |
| IL104112A0 (en) | 1993-05-13 |
| WO1993013117A2 (en) | 1993-07-08 |
| NZ246305A (en) | 1996-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE163422T1 (de) | Anti-proliferative -und anti-inflammatorische verbindungen: 5- oder6-deoxyhexose monosaccharide die, in 5- oder 6-stellung einen, über das stickstoffatom gebundenen gesättigten stickstoffhaltigen heterozyklen, haben | |
| Westermeyer | Mental health for refugees and other migrants: Social and preventive approaches. | |
| ATE246939T1 (de) | Monoamid, diamid, thiol enthaltende metall- chelatierende verbindungen | |
| DE69920757D1 (de) | Immunsuppressive wirkungen von pteridinderivaten | |
| FR2382232A1 (fr) | Compositions cosmetiques de traitement des cheveux | |
| ATE309249T1 (de) | Chemokin rezeptor antagonisten und verwndung | |
| DK0694545T3 (da) | Substituerede dibenzoxazepinforbindelser, farmaceutiske sammensætninger og anvendelsesmetoder | |
| DE3168595D1 (en) | New para-substituted 3-phenoxy-1-alkylamino-propanol-2-s having beta receptor blocking properties | |
| RU93053905A (ru) | Оксипуриновые нуклеозиды и родственные им соединения, а также их ацильные производные для улучшения гемопоэза, фармацевтическая композиция и способ лечения и/или профилактики | |
| DK0636027T3 (da) | Angiotensin-II-antogonister mod sygdomme forbundet med forringet neuronal ledningshastighed, især diabetisk neuropati | |
| UA27221C2 (uk) | Ефіри циклогексеноноксиму та гербіцидний засіб | |
| DE69427130D1 (de) | Ssi tyrphostine und pharmazeutische zusammensetzungen | |
| ATE47523T1 (de) | Pharmazeutische zusammensetzungen. | |
| DE69013787D1 (de) | Ammonium-verbindung, diese enthaltende zusammensetzung und desinfektionsverfahren. | |
| KR940702726A (ko) | 치환된 퀴놀린-3-카르복시아미드 화합물의 용도 및 이를 이용한 다발성 경화증의 치료방법 | |
| ATE238804T1 (de) | Immunomodulierende, entzündungshemmende und antiproliferative verbindungen:5,6-dideoxy, 5- aminoderivate von idose und 6-deoxy, 6- aminoderivate von glukose | |
| WO1992004359A3 (en) | Monosaccharides having anti-proliferation and anti-inflammatory activity, compositions and uses thereof | |
| DE3367070D1 (en) | Compositions comprising pepstatin and an histamine h2-receptor antagonist having an enhanced antiulcer activity | |
| ATE116851T1 (de) | 5-aryl-3h-1,2,4-triazol-3-one und ihre verwendung in der behandlung neurodegenerativer beschwerden. | |
| DK190983A (da) | 2,4-diamino-5-(substituerede)pyrimidiner, fremgangsmaade til deres fremstilling og mellemprodukter derfor | |
| FR2369293A1 (fr) | Derives de 4,6-di-o-(aminoglyco | |
| ITRM920305A0 (it) | Composizione farmaceutica per il trattamento dello shock, particolarmente dello shock cardiogeno e dello shock settico. | |
| NO932959L (no) | Antiprolifererende og antiinflammatoriske forbindelser: 5- eller 6-deoksyheksose-monosakkarider som har en mettet nitrogenholdig heterocyklus ved 5- eller 6-stillingen, bundet ved nitrogenatomet | |
| ATE88634T1 (de) | Arzneimittel zur behandlung von herzinsuffizienz. | |
| EP0324390A3 (de) | Nigericinderivate, Verfahren zu deren Herstellung, diese enthaltende Mittel und Verwendung derselben sowie die Verwendung von Nigericin als antiviral wirksame Substanz |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |